Specific Lesion Subsets

  • Gregory W. Barsness
  • John F. Bresnahan


One of the early lessons in interventional cardiology was the discovery that certain angiographic features were associated with poor acute outcome, in particular, abrupt or threatened occlusion [1,2]. Because these lesion characteristics accounted for a major portion of the morbidity related to balloon angioplasty, guidelines were developed in an effort to risk-stratify patients based on angiographic criteria and to dissuade intervention in high-risk subgroups [3].


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ellis SG, Roubin GS, King SB III, et al.: Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988, 77:372–379.PubMedGoogle Scholar
  2. 2.
    Myler RK, Shaw RE, Stertzer SH, et al.: Lesion morphology and coronary angioplasty: current experience and analysis.J Am Coll Cardiol 1992, 19:1641–1652.PubMedGoogle Scholar
  3. 3.
    Ryan TJ, Faxon DP, Gunnar RM, et al.: Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Coronary Angioplasty). J Am Coll Cardiol 1988, 12:529–545.Google Scholar
  4. 4.
    Ellis SG, Guetta V, Miller D, et al.: Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein IIb /IIIa era: an analysis of results from 10,907 lesions and proposal for new classification scheme. Circulation 1999, 100:1971–1976.PubMedGoogle Scholar
  5. 5.
    Topol EJ, Ellis SG, Fishman J, et al.: Multicenter study of percutaneous transluminal angioplasty for right coronary artery ostial stenosis.J Am Coll Cardiol 1987, 9:1214–1218.PubMedGoogle Scholar
  6. 6.
    Sabri MN, Cowley MJ, DiSciascio G, et al.: Immediate results of interventional devices for coronary ostial narrowing with angina pectoris. Am J Cardiol 1994, 73:122–125.PubMedGoogle Scholar
  7. 7.
    Jain SP, Liu MW, Dean LS, et al.: Comparison of balloon angioplasty versus debulking devices versus stenting in right coronary ostial lesions. Am J Cardiol 1997, 79:1334–1338.PubMedGoogle Scholar
  8. 8.
    Motwani JG, Raymond RE, Franco I, et al.: Effectiveness of rotational atherectomy of right coronary artery ostial stenosis. Am J Cardiol 2000, 85:563–567.PubMedGoogle Scholar
  9. 9.
    Rocha-Singh K, Morris N, Wong SC, et al.: Coronary stenting for treatment of ostial stenoses of native coronary arteries or aortocoronary saphenous venous grafts. Am J Cardiol 1995, 75:26–29.PubMedGoogle Scholar
  10. 10.
    Silvestri M, Barragan P, Sainsous J, et al.: Unprotected left main coronary artery stenting: immediate and medium-term outcomes of 140 elective procedures. J Am Coll Cardiol 2000, 35:1543–1550.PubMedGoogle Scholar
  11. 11.
    Amin FR, Horlitz M, Yousufuddin M, et al.: Acute and long-term clinical outcome of aorto-ostial vs non-aorto-ostial stenting. Am J Cardiol 2000; TCT abstracts:43i.Google Scholar
  12. 12.
    Rieu R, Barragan P, Masson C, et al.: Radial force of coronary stents: a comparative analysis. Cathet Cardiovasc Intervent 1999, 46:380–391.Google Scholar
  13. 13.
    Mathias DW, Mooney JF, Lange HW, et al.: Frequency of success and complications of coronary angioplasty of a stenosis at the ostium of a branch vessel. Am J Cardiol 1991, 67:491–495.PubMedGoogle Scholar
  14. 14.
    Tan KH, Sulke N, Taub N, Sowton E: Percutaneous transluminal coronary angioplasty of aorta ostial, non-aorta ostial, and branch ostial stenoses: acute and long-term outcome. Eur Heart J 1995, 16:631–639.PubMedGoogle Scholar
  15. 15.
    Al Suwaidi J, Berger PB, Rihal CS, et al.: Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions.J Am Coll Cardiol 2000, 35:929–936.PubMedGoogle Scholar
  16. 16.
    Peacock J, Jones T, Tock C, et al.: An in vitro study on the effect of branch points on the stability of coronary artery flow. Med Eng Phys 1997, 19:101–108.PubMedGoogle Scholar
  17. 17.
    Perktold K, Hofer M, Rappitsch G, et al.: Validated computation of physiologic flow in a realistic coronary artery branch.J Biomech 1998, 31:217–228.PubMedGoogle Scholar
  18. 18.
    Brener SJ, Leya FS, Apperson-Hanson C, et al.: A comparison of debulking versus dilatation of bifurcation coronary arterial narrowings (from the CAVEAT I trial). Am J Cardiol 1996, 78:1039–1041.PubMedGoogle Scholar
  19. 19.
    Dauerman HL, Higgins PJ, Sparano AM, et al.: Mechanical debulking versus balloon angioplasty for the treatment of true bifurcation lesions.J Am Coll Cardiol 1998, 32:1845–1852.PubMedGoogle Scholar
  20. 20.
    Rihal CS, Garratt KN, Holmes DR: Rotational atherectomy for bifurcation lesions of the coronary circulation: technical and initial experience. Int J Cardiol 1998, 65:1–9.PubMedGoogle Scholar
  21. 21.
    Oesterle SN: Coronary interventions at a crossroads: the bifurcation stenosis. J Am Coll Cardiol 1998, 32:1853–1854.PubMedGoogle Scholar
  22. 22.
    Pan M, Medina A, Suarez de Lezo J, et al.: Follow-up patency of side branches covered by intracoronary Palmaz-Schatz stent. Am Heart J 1995, 129:436–440.PubMedGoogle Scholar
  23. 23.
    Fischman DL, Savage MP, Leon MB, et al.: Rate of lesion-related side branches after coronary artery stenting. J Am Coll Cardiol 1993, 22:1641–1646.PubMedGoogle Scholar
  24. 24.
    Ellis SG, Lincoff AM, Miller D, et al.: Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. J Am Coll Cardiol 1998, 32:1619–1623.PubMedGoogle Scholar
  25. 25.
    Arora RR, Raymond RE, Dimas AP, et al.: Side branch occlusion during coronary angioplasty: incidence, angiographic characteristics, and outcome. Cathet Cardiovasc Diagn 1989, 18:210–212.PubMedGoogle Scholar
  26. 26.
    Stone GW, Rutherford BD, McConahay DR, et al.: Procedural outcome of angioplasty for total coronary artery occlusion: an analysis of 971 lesions in 905 patients. J Am Coll Cardiol 1990, 15:849–856.PubMedGoogle Scholar
  27. 27.
    Ivanhoe RJ, Weintraub WS, Douglas JS Jr, et al.: Percutaneous transluminal coronary angioplasty of chronic total occlusions. Circulation 1992, 85:106–115.PubMedGoogle Scholar
  28. 28.
    Bell MR, Berger PB, Bresnahan JF, et al.: Initial and long term outcome of 354 patients following coronary balloon angioplasty of total coronary artery occlusions. Circulation 1992, 85:1003–1011.PubMedGoogle Scholar
  29. 29.
    Ruocco NA, Ring ME, Holubkov R, et al.: Results of coronary angioplasty of chronic total occlusions (the National Heart, Lung, and Blood Institute 1985–1986 Percutaneous Transluminal Angioplasty Registry). Am J Coll Cardiol 1992, 69:69–76.Google Scholar
  30. 30.
    Haine E, Urban P, Dorsaz PA, Meier B: Outcome and complications of 500 consecutive chronic total occlusion angioplasties.J Am Coll Cardiol 1993, 2L138A.Google Scholar
  31. 31.
    Kinoshita I, Katoh O, Nariyama J, et al.: Coronary angioplasty of chronic total occlusions with bridging collateral vessels: immediate and follow-up outcome from a large single-center experience.J Am Coll Cardiol 1995, 26:409–415.PubMedGoogle Scholar
  32. 32.
    Noguchi T, Miyazaki S, Morii I, et al.: Percutaneous transluminal coronary angioplasty of chronic total occlusions. Determinants of primary success and long-term clinical outcome. Cathet Cardiovasc Interv 2000, 49:258–264.Google Scholar
  33. 33.
    Serruys PW, Hamburger JN, Koolen JJ, et al.: Total occlusion trial with angioplasty by using laser guidewire. The TOTAL trial. Eur Heart J 2000, 21:1737–1738.Google Scholar
  34. 34.
    Koolen JJ, Bonnier H, Grube E: A novel guiding system for facilitating the crossing of plaque and chronic total occlusions (abstract).J Am Coll Cardiol 2000, 35:40A.Google Scholar
  35. 35.
    Braden GA, Xenopoulos NP, Young T, et al.: Transluminal extraction catheter atherectomy followed by immediate stenting in treatment of saphenous vein grafts. J Am Coll Cardiol 1997, 30:657–663.PubMedGoogle Scholar
  36. 36.
    Waksman R, Weintraub WS, Ghazzal Z, et al.: Short- and long-term outcome of narrowed saphenous vein bypass graft: a comparison of Palmaz-Schatz stent, directional coronary atherectomy, and balloon angioplasty Am Heart J 1997, 134:274–281.PubMedGoogle Scholar
  37. 37.
    Buller CE, Dzavik V, Carere RG, et al.: Primary stenting versus balloon angioplasty in occluded coronary arteries: the total occlusion study of Canada (TOSCA). Circulation 1999, 100:236–242.PubMedGoogle Scholar
  38. 38.
    Hoher M, Wohrle J, Grebe OC, et al.: A randomized trial of elective stenting after balloon recanalization of chronic total occlusions.J Am Coll Cardiol 1999, 34:722–729.PubMedGoogle Scholar
  39. 39.
    Lotan C, Rozenman Y, Hendler A, et al.: Stents in total occlusion for restenosis prevention. The Multicentre randomized STOP study. The Israeli Working Group for Interventional Cardiology. Eur Heart J 2000, 21:1960–1966.PubMedGoogle Scholar
  40. 40.
    Hamburger JN, Serruys PW: The battle of Vladimir. Eur Heart J 2000, 21:1911–1913.PubMedGoogle Scholar
  41. 41.
    Katsuragawa M, Fujiwara H, Miyamae M, et al.: Histologic studies in percutaneous transluminal coronary angioplasty for chronic total occlusion: comparison of tapering and abrupt types of occlusion and short and long occluded segments. J Am Coll Cardiol 1993, 21:604–611.PubMedGoogle Scholar
  42. 42.
    Berger PB, Bresnahan J: Use of excimer laser in the treatment of chronic total occlusion of a coronary artery that cannot be crossed with a balloon catheter. Cathet Cardiovasc Diagn 1993, 28:44–46.PubMedGoogle Scholar
  43. 43.
    Fitzgerald PJ, Ports TA, Yock PG: Contribution of localized calcium deposits to dissection after angioplasty: an observational study using intravascular ultrasound. Circulation 1992, 86:64–70.PubMedGoogle Scholar
  44. 44.
    Komiyama N, Stone GW, Alderman EL, et al.: Relative stent expansion is dependent upon target segment calcification: an intravascular ultrasound assessment. Circulation 1996, 94 (suppl I):I—262.Google Scholar
  45. 45.
    Mintz GS, Popma JJ, Pichard AD, et al.: Patterns of calcification in coronary artery disease: a statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation l995, 91:1959–1965.PubMedGoogle Scholar
  46. 46.
    Moussa I, Di Mario C, Moses J, et al.: Coronary stenting after rotational atherectomy in calcified and complex lesions: angiographic and clinical follow-up results. Circulation 1997, 96:128–136.PubMedGoogle Scholar
  47. 47.
    Henneke KH, Regar E, Konig A, et al.: Impact of target lesion calcification on coronary stent expansion after rotational atherectomy. Am Heart J 1999, 137:93–99.PubMedGoogle Scholar
  48. 48.
    Hoffmann R, Mintz GS, Kent KM, et al.: Is there an optimal therapy for calcified lesions in large vessels? Comparative acute and follow-up results of rotational atherectomy, stents, or the combination.J Am Coll Cardiol 1997, 29:68A.Google Scholar
  49. 49.
    Ryan TJ, Bauman WB, Kennedy JW, et al.: Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/ American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1996, 88:2987–3007.Google Scholar
  50. 50.
    Savage MP, Goldberg S, Hirshfeld JW, et al.: Clinical and angiographic determinants of primary coronary angioplasty success.J Am Coll Cardiol 1991, 17:22–28.PubMedGoogle Scholar
  51. 51.
    Schunkert H, Harreil L, Palacious IF: Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization. J Am Coll Cardiol 1999, 34:40–48.PubMedGoogle Scholar
  52. 52.
    Hirshfeld JW, Schwartz JS, Jugo R, et al.: Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators.J Am Coll Cardiol 1991, 18:647–656.PubMedGoogle Scholar
  53. 53.
    Foley DP, Melkert R, Serruys PW: Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty Circulation 1994, 90:1239–1251.PubMedGoogle Scholar
  54. 54.
    Savage MP, Fischman DL, Rake R, et al.: Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries: Stent Restenosis Study (STRESS) Investigators.J Am Coll Cardiol 1998, 31:307–311.PubMedGoogle Scholar
  55. 55.
    Elezi S, Kastrati A, Neumann FJ, et al.: Vessel size and long-term outcome after coronary stent placement. Circulation 1998, 98:1875–1880.PubMedGoogle Scholar
  56. 56.
    Briguori C, Nishida T, Adamian M, et al.: Coronary stenting versus balloon angioplasty in small coronary artery with complex lesions. Cathet Cardiovasc Mew 2000, 50:390–397.Google Scholar
  57. 57.
    Kastrati A, Schomig A, Dirschinger J, et al.: A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. ISAR-SMART Study Investigators. Intracoronary stenting or angioplasty for restenosis reduction in small arteries. Circulation 2000, 102(21):2593–2598.PubMedGoogle Scholar
  58. 58.
    Sigwart U, Prasad S, Radke P, Nadra I: Stent coatings.J Invasive Cardiol 2001, 13(2):141–142, discussion 158–170.PubMedGoogle Scholar
  59. 59.
    Goudreau E, DiSciascio G, Kelly K, et al.: Coronary angioplasty of diffuse coronary artery disease. Am Heart J 1991, 121(1 pt 1):12–19.PubMedGoogle Scholar
  60. 60.
    Bergelson BA, Jacobs AK, Cupples LA, et al.: Prediction of risk for hemodynamic compromise during percutaneous transluminal coronary angioplasty. Am J Cardiol 1992, 70(20):1540–1545.PubMedGoogle Scholar
  61. 61.
    de Feyter PJ, de Jaegere PP, Serruys PW: Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty. Am Heart J 1994, 127(3):643–651.PubMedGoogle Scholar
  62. 62.
    Kaul U, Upasani PT, Agarwal R, et al.: In-hospital outcome of percutaneous transluminal coronary angioplasty for long lesions and diffuse coronary artery disease. Cathet Cardiovasc Diagn 1995, 35(4):294–300.PubMedGoogle Scholar
  63. 63.
    Cannon AD, Roubin GS, Hearn JA, et al.: Acute angiographic and clinical results of long balloon percutaneous transluminal coronary angioplasty and adjuvant stenting for long narrowings. Am J Cardiol 1994, 73(9):635–641.PubMedGoogle Scholar
  64. 64.
    Di Sciascio G, Patti G, Nasso G, et al.: Early and long-term results of stenting diffuse coronary artery disease. Am J Cardiol 2000, 86(11):1166–1170.PubMedGoogle Scholar
  65. 65.
    Kobayashi Y, DeGregorio J, Kobayashi N, et al.: Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999, 34(3):651–659.PubMedGoogle Scholar
  66. 66.
    Kastrati A, Elezi S, Dirschinger J, et al.: Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol 1999, 83:1617–1622.PubMedGoogle Scholar
  67. 67.
    Bauters C, Hubert E, Prat A, et al.: Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 1998, 31:1291–1298.PubMedGoogle Scholar
  68. 68.
    Kornowski R, Mehran R, Hong MK, et al.: Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions. Circulation 1998, 97:1355–1361.PubMedGoogle Scholar
  69. 69.
    Liu MW, Luo JF, Dean LS, et al.: Long-term follow-up study of coronary reconstruction with multiple stents. Am Heart J 1999, 137:292–297.PubMedGoogle Scholar
  70. 70.
    Rozenman Y, Mereuta A, Schechter D, et al.: Long-term outcome of patients with very long stents for treatment of diffuse coronary disease. Am Heart J 1999, 138:441–445.PubMedGoogle Scholar
  71. 71.
    DeGregorio J, Moussa I, Adamian M, et al.: The use of IVUS-guided PTCA and spot stenting for the treatment of long lesions: a comparison to traditional stenting. J Am Coll Cardiol 2000; abstracts-ACCIS 2000:62A.Google Scholar
  72. 72.
    White CJ, Ramee SR, Collins TJ, et al.: Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool. Circulation 1996, 93:253–258.PubMedGoogle Scholar
  73. 73.
    Vaitkus PT, Hermann HC, Laskey W: Management and immediate outcome of patients with intracoronary thrombus during percutaneous transluminal coronary angioplasty. Am Heart J 1992, 124:1–8.PubMedGoogle Scholar
  74. 74.
    Block PB, Peterson EC, Krone R, et al.: Identification of variables needed to risk-adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collection.J Am Coll Cardiol 1998, 32:275–282.PubMedGoogle Scholar
  75. 75.
    den Heijer P, Foley DP, Escaned J, et al.: Angioscopic versus angiographic detection of intimai dissection and intracoronary thrombus.J Am Coll Cardiol 1994, 24:649–654.Google Scholar
  76. 76.
    Cohen M, Demers C, Gurfinkel EP, et al.: A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997, 337:447–452.PubMedGoogle Scholar
  77. 77.
    Wallentin L: Low-molecular-weight heparins in coronary thrombosis: today and tomorrow. Haemostasis 1999, 29(suppl Sl):32–37.PubMedGoogle Scholar
  78. 78.
    Topol EJ: Evolution of improved antithrombotic and antiplatelet agents: genesis of the Comparison of Abciximab Complications with Hirulog [and Back-up Abciximab] Events Trial (CACHET). Am J Cardiol 1998, 82(8B):63P-68P.Google Scholar
  79. 79.
    Mehta SR, Yusuf S, Peters RJG, et al.: Effects of pretreatment with Clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001, 358:9281.Google Scholar
  80. 80.
    Cannon CP, Weintraub WS, Demopoulos LA, et al.: Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001, 344:1879–1887.PubMedGoogle Scholar
  81. 81.
    Mehran R, Ambrose JA, Bongu RM, et al.: Angioplasty of complex lesions in ischemic rest angina: results of the Thrombolysis and Angioplasty in Unstable Angina (TAUSA) trial. J Am Coll Cardiol 1995, 26:961–966.PubMedGoogle Scholar
  82. 82.
    Gold HK, Garabedian HD, Dinsmore RE, et al.: Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Observations in animals and humans. Circulation 1997, 95:1755–1759.PubMedGoogle Scholar
  83. 83.
    Muhlestein JB, Karagounis LA, Treehan S, et al.: “Rescue” utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty.J Am Coll Cardiol 1997, 30:1729–1734.PubMedGoogle Scholar
  84. 84.
    Mak KH, Challapalli R, Eisenberg MJ, et al.: Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. Am J Cardiol 1997, 80:985–988.PubMedGoogle Scholar
  85. 85.
    Ellis SG, Lincoff LM, Miller D, et al.: Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology: EPIC and EPILOG investigators.J Am Coll Cardiol 1998, 32:1619–1623.PubMedGoogle Scholar
  86. 86.
    Mathew V, Grill DE, Scott CG, et al.: The influence of abciximab use on clinical outcome after aortocoronary vein graft interventions.J Am Coll Cardiol 1999, 34:1163–1169.PubMedGoogle Scholar
  87. 87.
    Barsness GW, Buller C, Ohman EM, et al.: Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts. Am Heart J 2000, 139:824–829.PubMedGoogle Scholar
  88. 88.
    The PURSUIT Trial Investigators: Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrum Therapy. N Engl J Med 1998, 339:436–443.Google Scholar
  89. 89.
    O’Shea JC, Hafley GE, Greenberg S, et al.: Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial. JAMA 2001, 285:2468–2473.PubMedGoogle Scholar
  90. 90.
    PRISM-PLUS Study Investigators: Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q wave myocardial infarction. N Engl J Med 1998, 338:1488–1497.Google Scholar
  91. 91.
    Bhatt DL, Topol EJ: Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. JAMA 2000, 284:1549–1558.PubMedGoogle Scholar
  92. 92.
    Bailey SR, O’Leary E, Chilton R: Angioscopic evaluation of site-specific administration of ReoPro. Cathet Cardiovasc Diagn 1997, 42:181–184.PubMedGoogle Scholar
  93. 93.
    Kiesz RS, Buszman P, Martin JL, et al.: Local delivery of enoxaparin to decrease restenosis after stenting: results of initial multicenter trial: Polish-American Local Lovenox NIR Assessment study (The POLONIA study). Circulation 2001, 103:26–31.PubMedGoogle Scholar
  94. 94.
    Mitchel JF, Fram DB, Palme DF II, et al.: Enhanced intracoronary thrombolysis with urokinase using a novel, local delivery system: in vitro, in vivo, and clinical studies. Circulation 1995, 91:785–793.PubMedGoogle Scholar
  95. 95.
    Fram DB, Mitchel JF, Asrin MA, et al.: Local delivery of heparin to balloon angioplasty sites with a new angiotherapy catheter: pharmacokinetics and effect on platelet deposition in the porcine model. Cathet Cardiovasc Diagn 1997,41:275–286.PubMedGoogle Scholar
  96. 96.
    Silva JA, Ramee SR: The emergence of mechanical thrombectomy; a clot burden reduction approach. Semin Interv Cardiol 2000, 5:137–147.PubMedGoogle Scholar
  97. 97.
    Wheisenant BK, Bairn DS, Kuntz RE, et al.: Rheolytic thrombectomy with the Possis AngioJet? Technical considerations and initial clinical experience. J Invasive Cardiol 1999, 11:421–426.Google Scholar
  98. 98.
    Silva JA, Ramee SR, Cohen DJ, et al.: Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the Angiojet catheter. Am Heart J 2001, 141:353–359.PubMedGoogle Scholar
  99. 99.
    Rosenschein U, Roth A, Rassin T, et al.: Analysis of coronary ultrasound thrombolysis endpoints in acute myocardial infarction (ACUTE trial): results of the feasibility study. Circulation 1997, 95:1411–1416.PubMedGoogle Scholar
  100. 100.
    Safian RD, May MA, Lichtenberg A, et al.: Detailed clinical and angiographic analysis of transluminal extraction coronary atherectomy for complex lesions in native coronary arteries.J Am Coll Cardiol 1995, 25:848–854.PubMedGoogle Scholar
  101. 100a.
    Stone GW: X-sizer for treatment of thrombus and atherosclerosis in coronary interventions trial (X-TRACT) results. Presented at TCT, October 2002, Washington, DC.Google Scholar
  102. 101.
    Hong MK, Popma JJ, Pichard AD, et al.: Clinical significance of distal embolization after transluminal extraction atherectomy in diffusely diseased saphenous vein grafts. Am Heart J 1994, 127:1496–1503.PubMedGoogle Scholar
  103. 102.
    Holmes DR Jr, Topol EJ, Califf RM, et al.: A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions: CAVEAT-II Investigators. Circulation 1995,91:1966–1974.PubMedGoogle Scholar
  104. 103.
    Hong MK, Mehran R, Dangas G, et al.: Creatinine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999, 100(24):2400–2405.PubMedGoogle Scholar
  105. 104.
    Campeau L, Lesperance J, Hermann J, et al.: Loss of the improvement of angina between 1 and 7 years after aortocoronary bypass surgery: correlations with changes in vein grafts and in coronary arteries. Circulation 1979, 60(2 pt 2):l-5.Google Scholar
  106. 105.
    Bourassa MG, Enjalbert M, Campeau L, et al.: Progression of coronary artery disease between 10 and 12 years after coronary artery bypass graft surgery. In Prognosis of Coronary Heart Disease: Progression of Coronary Arteriosclerosis. Edited by Roskamm H. Berlin: Springer-Verlag; 1983:150.Google Scholar
  107. 106.
    Frick MH, Valle M, Harjola PT: Progression of coronary artery disease in randomized medical and surgical patients over a 5-year angiographic follow-up. Am J Cardiol 1983, 52:681.PubMedGoogle Scholar
  108. 107.
    Hwang MH, Meadows WR, Palac RT, et al.: Progression of native coronary artery disease at 10 years: insights from a randomized study of medical versus surgical therapy for angina. J Am Coll Cardiol 1990, 16:1066–1070.PubMedGoogle Scholar
  109. 108.
    108.Corbelli J, Franco I, Hollman J, et al.: Percutaneous transluminal coronary angioplasty after previous coronary artery bypass surgery. Am J Cardiol 1985, 56:398–403.PubMedGoogle Scholar
  110. 109.
    Douglas JS Jr, Gruentzig AR, King SB III, et al.: Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery. J Am Coll Cardiol 1983, 2:745–754.PubMedGoogle Scholar
  111. 110.
    Ernst SM, van der Feltz TA, Ascoop CA, et al.: Percutaneous transluminal coronary angioplasty in patients with prior coronary artery bypass grafting. Long-term results.J Thorac Cardiovasc Surg 1987, 93:268–275.PubMedGoogle Scholar
  112. 111.
    Mathew V, Clavell AL, Lennon RJ, et al.: Percutaneous coronary interventions in patients with prior coronary artery bypass surgery: changes in patient characteristics and outcome during two decades. Am J Med 2000, 108:127–135.PubMedGoogle Scholar
  113. 112.
    Morrison DA, Crowley ST, Veerakul G, et al.: Percutaneous transluminal angioplasty of saphenous vein grafts for medically refractory unstable angina. J Am Coll Cardiol 1994, 23:1066–1070.PubMedGoogle Scholar
  114. 113.
    Stephan WJ, O’Keefe JH Jr, Piehler JM, et al.: Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery. J Am Coll Cardiol 1996, 28:1140–1146.PubMedGoogle Scholar
  115. 114.
    Gruberg L, Hong MK, Mehran R, et al.: In-hospital and long-term results of stent deployment compared with balloon angioplasty for treatment of narrowing at the saphenous vein graft distal anastomosis site. Am J Cardiol 1999, 84:1381–1384.PubMedGoogle Scholar
  116. 115.
    Plokker HW, Meester BH, Serruys PW: The Dutch experience in percutaneous transluminal angioplasty of narrowed saphenous veins used for aortocoronary arterial bypass. Am J Cardiol 1991, 67(5):361–366.PubMedGoogle Scholar
  117. 116.
    Pomerantz RM, Kuntz RE, Carrozza JP, et al.: Acute and long-term outcome of narrowed saphenous venous grafts treated by endoluminal stenting and directional atherectomy. Am J Cardiol 1992, 70:161–167.PubMedGoogle Scholar
  118. 117.
    Waksman R, Popma JJ, Kennard ED, et al.: Directional coronary atherectomy (DCA): A report from the new approaches to coronary intervention (NACI) registry. Am J Cardiol 1997, 80(10A):50K-59K.Google Scholar
  119. 118.
    Waksman R, Weintraub WS, Ghazzal Z, et al.: Short- and long-term outcome of narrowed saphenous vein bypass graft: a comparison of Palmaz-Schatz stent, directional coronary atherectomy, and balloon angioplasty. Am Heart J 1997, 134(2 Pt 1):274–81.PubMedGoogle Scholar
  120. 119.
    Braden GA, Xenopoulos NP, Young T, et al.: Transluminal extraction catheter atherectomy followed by immediate stenting in treatment of saphenous vein grafts. J Am Coll Cardiol 1997, 30(3):657–663.PubMedGoogle Scholar
  121. 120.
    Dooris M, Hoffmann M, Glazier S, et al.: Comparative results of transluminal extraction coronary atherectomy in saphenous vein graft lesions with and without thrombus. J Am Coll Cardiol 1995, 25(7):1700–1705.PubMedGoogle Scholar
  122. 121.
    Meany TB, Leon MB, Kramer BL, et al.: Transluminal extraction catheter for the treatment of diseased saphenous vein grafts: a multicenter experience. Cathet Cardiovasc Diagn 1995, 34:112–120.PubMedGoogle Scholar
  123. 122.
    Misumi K, Matthews RV, Sun GW, et al.: Reduced distal embolization with transluminal extraction atherectomy compared to balloon angioplasty for saphenous vein graft disease. Cathet Cardiovasc Diagn 1996, 39:246–251.PubMedGoogle Scholar
  124. 123.
    Moses JW, Maussa I, Popma JJ, et al.: Risk of distal embolization and infarction with transluminal extraction atherectomy in saphenous vein grafts and native coronary arteries. Catheter Cardiovasc Interv 1999, 47:149–154.PubMedGoogle Scholar
  125. 124.
    124.Safian RD, Grines CL, May MA, et al.: Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts. Circulation 1994, 89:302–312.PubMedGoogle Scholar
  126. 125.
    Sketch MH, Davidson CJ, Yeh W, et al.: Predictors of acute and long-term outcome with transluminal extraction atherectomy: the new approaches to coronary intervention (NACI) registry. Am J Cardiol 1997, 80(10A):68K-77K.Google Scholar
  127. 126.
    Bittl JA, Sanborn TA, Yardley DE, et al.: Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. Am J Cardiol 1994, 74:144–148.PubMedGoogle Scholar
  128. 127.
    Natarajan MK, Bowman KA, Chisholm RJ, et al.: Excimer laser angioplasty vs. balloon angioplasty in saphenous vein bypass grafts: quantitative angiographic comparison of matched lesions. Cathet Cardiovasc Diagn 1996, 38:153–158.PubMedGoogle Scholar
  129. 128.
    Strauss BH, Natarajan MK, Batchelor WB, et al.: Early and late quantitative angiographic results of vein graft lesions treated by excimer laser with adjunctive balloon angioplasty. Circulation 1995, 92:348–356.PubMedGoogle Scholar
  130. 129.
    Savage MP, Douglas JS Jr, Fischman DL, et al.: Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts: Saphenous Vein De Novo Trial Investigators. N Engl J Med 1997, 337:740–747.PubMedGoogle Scholar
  131. 130.
    Bhargava B, Kornowski R, Mehran R, et al.: Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting. J Am Coll Cardiol 2000, 35(2):389–397.PubMedGoogle Scholar
  132. 131.
    Brener SJ, Ellis SG, Apperson-Hansen C, et al.: Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years. Am J Cardiol 1997, 79(1):13–18.PubMedGoogle Scholar
  133. 132.
    132.Fenton SH, Fischman DL, Savage MP, et al.: Long-term angiographic and clinical outcome after implantation of balloon-expandable stents in aortocoronary saphenous vein grafts. Am J Cardiol 1994, 74:1187–1191.PubMedGoogle Scholar
  134. 133.
    133.Frimerman A, Rechavia E, Eigler N, et al.: Long-term follow-up of a high risk cohort after stent implantation in saphenous vein grafts.J Am Coll Cardiol 1997, 30(5):1277–1283.PubMedGoogle Scholar
  135. 134.
    Herz I, Assali A, Adler Y, et al.: Coronary stent deployment without predilation: prevention of complications of venous graft angioplasty. Angiology 1998, 49(8):613–617.PubMedGoogle Scholar
  136. 135.
    Hong MK, Mehran R, Dangas G, et al.: Are we making progress with percutaneous saphenous vein graft treatment? J Am Coll Cardiol 2001, 38:150–154.PubMedGoogle Scholar
  137. 136.
    Kornowski R, Mehran R, Hong MK, et al.: Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions. Circulation 1998, 97(14):1355–1361.PubMedGoogle Scholar
  138. 137.
    Le May MR, Labinaz M, Marquis JF, et al.: Predictors of long-term outcome after stent implantation in a saphenous vein graft. Am J Cardiol 1999, 83(5):681–686.PubMedGoogle Scholar
  139. 138.
    Maiello L, Colombo A, Gianrossi R, et al.: Favourable results of treatment of narrowed saphenous vein grafts with Palmaz-Schatz stent implantation. Eur Heart J 1994, 15:1212–1216.PubMedGoogle Scholar
  140. 139.
    Keeley EC, Velez CA, O’Neill WW, et al.: Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts.J Am Coll Cardiol 2001, 38:659–665.PubMedGoogle Scholar
  141. 140.
    Wong SC, Bairn DS, Schatz RA, et al.: Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. The Palmaz-Schatz Stent Study Group. J Am Coll Cardiol 1995, 26:704–712.PubMedGoogle Scholar
  142. 141.
    Foley DP, Wijns W, Suryapranata H, et al.: Bypass graft angioplasty using the self-expanding, less-shortening Wallstent — results of the Wallstent CABG study. Eur Heart J 1997, 18(Suppl):157.Google Scholar
  143. 142.
    Safian RD, Kaplan B, Schreiber T, et al.: Interim results of the Wallstent endoprosthesis in saphenous vein graft trial (WINS). Circulation 1998, (Suppl I) 98:1–662.Google Scholar
  144. 143.
    Strauss BH, Serruys PW, Bertrand ME, et al.: Quantitative angiographic follow-up of the coronary Wallstent in native vessels and bypass grafts (European experience-March 1986 to March 1990). Am J Cardiol 1992, 69:475–481.PubMedGoogle Scholar
  145. 144.
    von Birgelen C, Airiian SG, de Feyter PJ, et al.: Coronary Wallstents show significant late, postprocedural expansion despite implantation with adjunct high-pressure balloon inflations. Am J Cardiol 1998, 82(2):129–134.Google Scholar
  146. 145.
    Caputo RP, Amin N, Marvasti M, et al.: Successful treatment of asaphenous vein graft perforation with an autologous vein-covered stent. Catheter Cardiovasc Interv 1999, 48(4):382–386.PubMedGoogle Scholar
  147. 146.
    Wong SC, Kent KM, Mintz GS, et al.: Percutaneous transcatheter repair of a coronary aneurysm using a composite autologous cephalic vein-coated Palmaz-Schatz biliary stent. Am J Cardiol 1995, 76:990–991.PubMedGoogle Scholar
  148. 147.
    Di Mario C, Inglese L, Colombo A: Treatment of a coronary aneurysm with a new polytetrafluoroethylene-coated stent: a case report. Cathet Cardiovasc Intervent 1999, 46:463–465.Google Scholar
  149. 148.
    Haager PK, Dechene A, Radke PW, et al.: Acute and long-term results with an endoluminal polytetrafluoroethylene stent graft in patients with in-stent restenosis and venous coronary artery bypass grafts. Circulation 1999, (Suppl I), 100(18):1–294.Google Scholar
  150. 149.
    Baldus S, Koster R, Eisner M, et al.: Treatment of aortocoronary vein graft lesions with membrane covered stents: a multicenter surveillance trial. Circulation 2000, 201:2024–2027.Google Scholar
  151. 150.
    Silva JA, White CJ, Collins TJ, Ramee SR: Morphologic comparison of atherosclerotic lesions in native coronary arteries and saphenous vein grafts with intracoronary angioscopy in patients with unstable angina. Am Heart J 1998, 136:156–163.PubMedGoogle Scholar
  152. 151.
    Bourassa MG, Fisher LD, Campeau L, et al.: Long-term fate of bypass grafts: the coronary artery surgery study (CASS) and Montreal Heart Institute experiences. Circulation 1985, 72(Pt 2):V71-V78.Google Scholar
  153. 152.
    Fernandez-Ortiz A, Badimon JJ, Falk E, et al.: Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994, 23:1562–1569.PubMedGoogle Scholar
  154. 153.
    Webb JG, Myler RK, Shaw RE, et al.: Coronary angioplasty after coronary bypass surgery: initial results and late outcome in 422 patients.J Am Coll Cardiol 1990, 16:812–820.PubMedGoogle Scholar
  155. 154.
    Lefkovits J, Holmes DR, Califf RM, et al.: Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial: Coronary Angioplasty Versus Excisional Atherectomy Trial. Circulation 1995, 92:734–740.PubMedGoogle Scholar
  156. 155.
    Webb JG, Carere RG, Virmani R, et al.: Retrieval and analysis of particulate debris after saphenous vein graft intervention.J Am Coll Cardiol 1999, 34(2):468–475.PubMedGoogle Scholar
  157. 156.
    Teirstein PS, Mann JT, Cundey PE Jr, et al.: Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion. Am J Cardiol 1999, 83(12):1623–1628.PubMedGoogle Scholar
  158. 157.
    Carlino M, DeGregorio J, DiMario C, et al.: Prevention of distal embolization during saphenous vein graft lesion angioplasty: experience with a new temporary occlusion and aspiration system. Circulation 1999, 99(25):3221–3223.PubMedGoogle Scholar
  159. 158.
    Bairn DS, Wahr D, George B, et al.: Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aortocoronary bypass grafts. Circulation 2002, 105:1285–1290.Google Scholar
  160. 159.
    Ohki T, Roubin GS, Vieth FJ, et al.: Efficacy of a filter device in the prevention of embolic events during carotid angioplasty and stenting: an ex-vivo analysis.J Vasc Surg 1999, 30:1034–1044.PubMedGoogle Scholar
  161. 160.
    Glazier JJ, Bauer HH, Kiernan FJ, et al.: Recanalization of totally occluded saphenous vein grafts using local urokinase delivery with the dispatch catheter. Cathet Cardiovasc Diagn 1995, 36:326–332.PubMedGoogle Scholar
  162. 161.
    Hartmann JR, McKeever LS, O’Neill WW, et al.: Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts with long-term, low dose direct infusion of urokinase (ROBUST): a serial trial.J Am Coll Cardiol 1996, 27:60–66.PubMedGoogle Scholar
  163. 162.
    Holmes DR Jr, Berger P: Percutaneous revascularization of occluded vein grafts: Is it still a temptation to be resisted? Circulation 1999, 99:8–11.PubMedGoogle Scholar
  164. 163.
    Rosenschein U, Gaul G, Erbel R, et al.: Percutaneous transluminal therapy of occluded saphenous vein grafts: Can the challenge be met with ultrasound thrombolysis? Circulation 1999, 99(l):26–29.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Gregory W. Barsness
  • John F. Bresnahan

There are no affiliations available

Personalised recommendations